Supplies - 325000-2020

10/07/2020    S132

North Macedonia-Skopje: Diagnostic agents

2020/S 132-325000

Contract notice

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Ss. Cyril and Methodius University Faculty of Medicine Skopje
Postal address: 50 Divizija, No.6
Town: Skopje
NUTS code: 00 Not specified
Postal code: 1000
Country: North Macedonia
Contact person: Irena Georgievska
E-mail: j.nabavki@medf.ukim.edu.mk
Telephone: +389 3103728

Internet address(es):

Main address: http://www.medf.ukim.edu.mk/

I.2)Information about joint procurement
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://www.e-nabavki.gov.mk/
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://www.e-nabavki.gov.mk/
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Education

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Tests for Serology Diagnosis of Infections, Identification of Microorganisms

II.1.2)Main CPV code
33694000 Diagnostic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Tests for serology diagnosis of infections, identification of microorganisms.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description
II.2.1)Title:

Echinococcosis Antigen for Indirect Haemagglutinin Testing, for Serum Antibody Testing, with Positive and Negative Control Included

Lot No: 1
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Echinococcosis antigen for indirect haemagglutinin testing, for serum antibody testing, with positive and negative control included.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Agglutination test for Streptococcus gr antigens. ABCDFG, isolated in pure culture; with positive control

Lot No: 2
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Agglutination test for Streptococcus gr antigens. ABCDFG, isolated in pure culture; with positive control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Agglutination test for Cryptococcus antigens in human specimens, serum, and liquor, with positive control included

Lot No: 3
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Agglutination test for Cryptococcus antigens in human specimens, serum, and liquor, with positive control included

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Agglutination test to prove MRSA (methicillin-resistant Staphylococcus aureus) isolated in pure culture with positive control

Lot No: 4
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Agglutination test to prove MRSA (methicillin-resistant Staphylococcus aureus) isolated in pure culture with positive control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Agglutination test for proving antigens of 6 most common causes of meningitis, for direct proof in liquor, with included positive and negative control

Lot No: 5
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Agglutination test for proving antigens of 6 most common causes of meningitis, for direct proof in liquor, with included positive and negative control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Haemophilus influenzae group antigen-tested agglutination test b isolated in pure culture, with positive control

Lot No: 6
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Haemophilus influenzae group antigen-tested agglutination test b isolated in pure culture, with positive control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Latex agglutination test for detection of Cl difficile, with included positive control, with included cards and agglutination sticks, with minimum sensitivity 95 % and with minimum specificity 95 %

Lot No: 7
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Latex agglutination test for detection of Cl difficile, with included positive control, with included cards and agglutination sticks, with minimum sensitivity 95 % and with minimum specificity 95 %

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for detection of Candida manganese antigen in human specimens: microtiter plate with 96 wells coated with anti-mannan monoclonal antibodies EBCA-1, wash buffer (buffer solution, concentrat

Lot No: 8
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for detection of Candida manganese antigen in human specimens: microtiter plate with 96 wells coated with anti-mannan monoclonal antibodies EBCA-1, wash buffer (buffer solution, concentrated) min. 70 ml, Calibrator 0 - Tris NaCl Trehalose Buffer, min. 2 ml, Calibrator 62.5 - Tris NaCl Trehalose Buffer, min. 2 ml, calibrator 125 -Tris NaCl tracheal buffer, min. 2 ml, calibrator 250 - Tris NaCl Trehalose Buffer, min. 2 ml, calibrator 500 - Tris NaCl Trehalose Buffer, min. 2 ml, conjugate anti-mannan monoclonal antibody marked with peroxidase min. 17 ml, positive control (serum containing Candida manganese antigen) min. 1.5 mL, negative control (human serum containing no Candida manganese antigen) min 1.5 mL, TMB substrate (chromogen -3,3 ’, 5,5’-tetramethylbenzidine) min. 28 ml, stop reagent min. 28 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for the detection of Aspergillus galactomannan antigen in human specimens: a microtiter plate with 96 wells coated with anti-galactomanone monoclonal antibodies, buffer wash (buffer solutio

Lot No: 9
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for the detection of Aspergillus galactomannan antigen in human specimens: a microtiter plate with 96 wells coated with anti-galactomanone monoclonal antibodies, buffer wash (buffer solution, concentrated) min. 70 ml, conjugate anti-galactomannan monoclonal antibody marked with peroxidase min. 8 ml, positive control (serum containing Aspergillus galactomannan antigen) min. 1.7 mL, negative control (human serum containing no Aspergillus galactomannan antigen) min 1.7 mL, TMB substrate (chromogen-3,3 ’, 5,5’-tetramethylbenzidine) min. 28 ml, stop reagent min. 28 ml.

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for proof of Legionella antigen in urine (double antigen ELISA sandwich), to contain a minimum of microtracheal flux divided into strips with a maximum of 96 wells coated with rabbit-speci

Lot No: 10
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for proof of Legionella antigen in urine (double antigen ELISA sandwich), to contain a minimum of microtracheal flux divided into strips with a maximum of 96 wells coated with rabbit-specific ant-legionella antibodies, enzyme enzyme estrus substituted with enzyme; buffers, stop solution; positive, negative control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for detection of Entamoeba antigen from faeces: microtiter plate with a maximum of 96 wells (divisible into strips) coated with specific antibodies to the antigen of Entamoeba histolytica

Lot No: 11
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for detection of Entamoeba antigen from faeces: microtiter plate with a maximum of 96 wells (divisible into strips) coated with specific antibodies to the antigen of Entamoeba histolytica and Entamoeba dispar, buffer 100 ml for dilution, dilution of the sample (buffer) washing (buffer solution, concentrated) min 100 ml, positive control (inactivated antigen of Entamoeba) min 2 ml, negative control (buffer) min 2 ml, conjugate 1 (antibodies to entamoeba conjugated with biotin, in stabilized protein solution) min. 11 ml, conjugate 2 (Streptavidin poly-peroxidaza conjugate in a stabilized protein solution) min. 11 ml, substrate (chromogen, tetra-methyl-benzidine and peroxide) min. 13 ml, stop reagent min. 8 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for detection of Taenia solium IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divided into strips), sample dilution buffer (puffed solution) min 60 ml, washin

Lot No: 12
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for detection of Taenia solium IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divided into strips), sample dilution buffer (puffed solution) min 60 ml, washing buffer (buffer solution, concentrated) 25 ml, positive control (serum with antibodies specific to Taenia solium) min 1 ml, negative control (human serum without antibodies to Taenia solium) min 2 ml, conjugate (buffer with Protein A conjugated with peroxidase) min. 11 ml, TMB substrate (chromogen, tetra-methyl-benzidine) min. 11 ml, stop reagent min. 11 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA test for detection of Ascaris IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divisible into strips), sample dilution buffer (buffer solution) min 60 ml, washing buf

Lot No: 13
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA test for detection of Ascaris IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divisible into strips), sample dilution buffer (buffer solution) min 60 ml, washing buffer (buffer solution, concentrated) min ml, positive control (serum with antibodies specific to Ascaris) min 1 ml, negative control (human serum without antibodies to Ascaris) min 2 ml, conjugate (buffer with Protein A conjugated with peroxidase) min. 11 ml, TMB substrate (chromogen, tetra-methyl-benzidine) min. 11 ml, stop reagent min. 11 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA antigen detection test on Cryptosporidium parvum and Cryptosporidium hominis from feces: microtiter plate with a maximum of 96 wells (divided into strips) coated with specific antibodies

Lot No: 14
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA antigen detection test on Cryptosporidium parvum and Cryptosporidium hominis from feces: microtiter plate with a maximum of 96 wells (divided into strips) coated with specific antibodies to the antigen of the Cryptosporidium buffer solution 100mmin. ml, wash buffer (buffer solution, concentrated, thimerosal) min 100 ml, positive control (inactivated Cryptosporidium antigen) min 2 ml, negative control (buffer) min 2 ml, conjugate 1 (antibodies to specific CGs of Cryptosporidium AG biotin, in a stabilized protein solution) min. 11 ml, conjugate 2 (Streptavidin poly-peroxidaza conjugate in a stabilized protein solution) min. 11 ml, substrate (chromogen, tetra-methyl-benzidine and peroxide) min. 13 ml, stop reagent min. 8 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

ELISA IgG Detection Test Specific to E. histolytica (Amebiasis)

Lot No: 15
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

ELISA IgG Detection Test Specific to E. histolytica (Amebiasis)

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Diagnostic test for quantitative determination of (1> 3) -beta-D-GLUCAN in serum or plasma by kinetic turbidimetric method. The test should be monotonous, the calibration should be done with the help

Lot No: 16
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Diagnostic test for quantitative determination of (1> 3) -beta-D-GLUCAN in serum or plasma by kinetic turbidimetric method. The test should be monotonous, the calibration should be done with the help of a QR scanner. Reagents should be ready for use. LAL (Limulus Amebocyte Lysate) based principle. The test time should be max. 90min. Measurement range: 6-600 pg / ml. Cut-off value: 11pg / ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Microimmunofluorescence test for the detection of specific IgM, IgA, and IgG antibodies to Chlamydia trachomatis; microscopic glass with applied antigens (LPS) of specifics or serotypes of purified el

Lot No: 17
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Microimmunofluorescence test for the detection of specific IgM, IgA, and IgG antibodies to Chlamydia trachomatis; microscopic glass with applied antigens (LPS) of specifics or serotypes of purified elemental bodies of Chlamydia trachomatis; semi-quantitative test for determination of titers of IgM, IgA and IgG antibodies; with controls (positive and negative human serum specifically for IgG, IgM, and IgA) and antihuman immunoglobulins conjugated with fluorescein (FITC reagent)

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Group: 142. TESTS FOR IMMUNOFLUORESCENTION (PNEUMOSLAGE) (The Lot is not divisible)

Lot No: 18
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Group: 142. TESTS FOR IMMUNOFLUORESCENTION (PNEUMOSLAGE) (Lot is not divisible):

— indirect immunofluorescence test for respiratory pathogens causing atypical pneumonia; slides with applied antigens on 9 different microorganisms (bacteria Legionella pneumophila, Mycoplasma pneumoniae, Coxiella burnetii, Chlamydophila pneumoniae and viruses Adenovirus, RSV, Influenza A, Influenza B, Parainfluenza 1, 2 and 3) for IgG

— indirect immunofluorescence test for respiratory pathogens causing atypical pneumonia; slides with applied antigens to 9 different microorganisms (bacteria Legionella pneumophila, Mycoplasma pneumoniae, Coxiella burnetii, Chlamydophila pneumoniae and viruses Adenovirus, RSV, Influenza A, Influenza B, Parainfluenza 1, 2 and 3) for IgM

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella O4; with a minimum volume of 2 ml

Lot No: 19
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella O4; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella O9; with a minimum volume of 2 ml

Lot No: 20
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella O9; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella Hg, m, with a minimum volume of 2 ml

Lot No: 21
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella Hg, m, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella Hm; with a minimum volume of 2 ml

Lot No: 22
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella Hm; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella flexneri (types: I, II, III, IV, V, VI), with a minimum volume of 2 ml

Lot No: 23
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella flexneri (types: I, II, III, IV, V, VI), with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Antiserum for Yersinia enterocolitica O3, with a minimum volume of 2 ml

Lot No: 24
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Antiserum for Yersinia enterocolitica O3, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Antiserum for Yersinia enterocolitica O9, with a minimum volume of 2 ml

Lot No: 25
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Antiserum for Yersinia enterocolitica O9, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Salmonella O-groups from A to S, with a minimum volume of 2 ml

Lot No: 26
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Salmonella O-groups from A to S, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Salmonella phase 1 and 2 (from a to z29), with a minimum volume of 2 ml

Lot No: 27
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Salmonella phase 1 and 2 (from a to z29), with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Salmonella stage 2 (from H to l), with a minimum volume of 2 ml

Lot No: 28
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Salmonella stage 2 (from H to l), with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella dysenteriae types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml

Lot No: 29
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella dysenteriae types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella dysenteriae types 8, 9, 10, 11, 12, with a minimum volume of 2 ml

Lot No: 30
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella dysenteriae types 8, 9, 10, 11, 12, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella boydii types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml

Lot No: 31
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella boydii types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella boydii types 8, 9, 10, 11, with a minimum volume of 2 ml

Lot No: 32
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella boydii types 8, 9, 10, 11, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella boydii types 12, 13, 14, 15, with a minimum volume of 2 ml

Lot No: 33
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella boydii types 12, 13, 14, 15, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella boydii types 16, 17, 18, with a minimum volume of 2 ml

Lot No: 34
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella boydii types 16, 17, 18, with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella H e, h; with a minimum volume of 2 ml

Lot No: 35
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella H e, h; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella H G; with a minimum volume of 2 ml

Lot No: 36
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella H G; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella H 2; with a minimum volume of 2 ml

Lot No: 37
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella H 2; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Antiserum for Salmonella H 5; with a minimum volume of 2 ml

Lot No: 38
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Antiserum for Salmonella H 5; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella H g, p; with a minimum volume of 2 ml

Lot No: 39
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella H g, p; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Anti-serum for Salmonella H p; with a minimum volume of 2 ml

Lot No: 40
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Anti-serum for Salmonella H p; with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Polyvalent serum for Shigella sonnei D (Phase I, Phase II); with a minimum volume of 2 ml

Lot No: 41
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Polyvalent serum for Shigella sonnei D (Phase I, Phase II); with a minimum volume of 2 ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Immunochromatographic test for proving Rotavirus / Adenovirus antigens in feces, with low positive control, with a minimum sensitivity of 90 % and a minimum specificity of 99 %

Lot No: 42
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Immunochromatographic test for proving Rotavirus / Adenovirus antigens in feces, with low positive control, with a minimum sensitivity of 90 % and a minimum specificity of 99 %

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Immunochromatographic test for detection of Cl difficile glutamate dehydrogenase in feces, with positive control included, with 99 % sensitivity, 99 % specificity and analytical sensitivity: 0.39 ng / m

Lot No: 43
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Immunochromatographic test for detection of Cl difficile glutamate dehydrogenase in feces, with positive control included, with 99 % sensitivity, 99 % specificity and analytical sensitivity: 0.39 ng / ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Helicobacter pylori antigen immunogenomatographic test in faeces, with positive control included, with a minimum sensitivity of 99 %, a specificity of 99 % and a detection limit of 10 ng / ml

Lot No: 44
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Helicobacter pylori antigen immunogenomatographic test in faeces, with positive control included, with a minimum sensitivity of 99 %, a specificity of 99 % and a detection limit of 10 ng / ml

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Immunochromatographic test for Rota virus in feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 %

Lot No: 45
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Immunochromatographic test for Rota virus in feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 %

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Immunochromatographic test for detection of toxins A and B separately, in Clostridium difficile directly from feces, with positive control included, with a minimum specificity of 99 % and a sensitivit

Lot No: 46
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Immunochromatographic test for detection of toxins A and B separately, in Clostridium difficile directly from feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 %

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Indirect immunofluorescence (IIF) for Leshmania donovani (IgG, IgM); slides with applied antigens, with included positive and negative control

Lot No: 47
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Indirect immunofluorescence (IIF) for Leshmania donovani (IgG, IgM); slides with applied antigens, with included positive and negative control

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Direct immunofluorescence (DIF) for Chlamydia trachomatis; slides with autumn protein (MOMP) antigen of C trachomatis, with positive control included

Lot No: 48
II.2.2)Additional CPV code(s)
33694000 Diagnostic agents
II.2.3)Place of performance
NUTS code: 00 Not specified
II.2.4)Description of the procurement:

Direct immunofluorescence (DIF) for Chlamydia trachomatis; slides with autumn protein (MOMP) antigen of C trachomatis, with positive control included

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

— statement by the economic operator that it has not been sentenced, in the last 5 years, with effective Court decision for participation in criminal organisation, corruption, fraud or money laundering;

— certificate that it is not subject to bankruptcy procedure issued by competent authority,

— certificate that it is not subject to liquidation procedure issued by competent authority,

— certificate for paid taxes, contributions and other public dues by the competent authority in the country where that economic operator is established;

— certificate from the legal entities penal registry that it is not being imposed a side sanction,

— prohibition to participate in public competitions, public procurement contract award and public,

— private partnership contract award procedures,

— certificate from the legal entities penal registry that it is not being imposed a side sanction,

— temporary or permanent prohibition to perform certain professional activity,

— certificate that it is not being sanctioned for misdemeanor with an effective court decision, resulting in prohibition for pursuing professional activity or duty, i.e. temporary prohibition for performing certain business activity.

Ability of the economic operator to perform business activity:

— document for registered business activity,

— certificate for wholesale of medical devices in accordance with the Law on medicines and medical devices.

III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:

Contract performance guarantee: Bank guarantee of 10 %

III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 06/08/2020
Local time: 10:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
Macedonian
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders
Date: 06/08/2020
Local time: 10:00
Place:

Electronically, ESJN (https://www.e-nabavki.gov.mk/); Ss. Cyril and Methodius University, Faculty of Medicine — Skopje, 50 Divizija No 6, 1000 Skopje, REPUBLIC of MACEDONIA.

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: yes
Estimated timing for further notices to be published:

Year 2021.

VI.2)Information about electronic workflows
VI.4)Procedures for review
VI.4.1)Review body
Official name: State Appeals Commission for Public Procurement
Town: Skopje
Country: North Macedonia

Internet address: http://www.dkzjn.gov.mk/

VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
07/07/2020